A drug to shrink double chins?

German drugmaker Bayer is in late-stage trials for a nonsurgical "cure" for the double chin. How does it work?

If drug trials go well, you may soon be able to "shrink" your double chin with 40-70 injections of ATX-101, administered over a period of weeks.
(Image credit: Corbis)

Forget the diets and "eat less" New Year's resolutions: German drugmaker Bayer says it's on the cusp of selling a cure for the "dreaded double chin." The injectable drug is being tested on 720 patients across Europe, and if it passes muster, it could be available in Europe, Latin America, and Asia by 2014. Just how does Bayer propose to rid us of the "curse of middle age" without invasive cosmetic surgery? A guide:

What does the drug do?

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us